K A Foon - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

K A Foon

Showing results (161-170 of 184) with videos related to

Pageof 19

Sort By:

Annals of Internal Medicine|October 1, 1984

Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomasP A Bunn, K A Foon, D C Ihde, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984

Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administrationR K Oldham, K A Foon, A C Morgan, et al.

Blood|November 1, 1984

Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemiaK A Foon, R W Schroff, P A Bunn, et al.

The American Journal of Medicine|March 1, 1986

Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia. Therapeutic and immunologic resultsK A Foon, A E Maluish, P G Abrams, et al.

Hybridoma|January 1, 1985

The generation of stable human T-cell hybridomas which constitutively produce interleukin-2 and chemotactic factorK A Foon, J L Rossio, R W Schroff, et al.

Cancer Research|November 15, 1987

Fate of gamma-interferon-activated killer blood monocytes adoptively transferred into the abdominal cavity of patients with peritoneal carcinomatosisH C Stevenson, A M Keenan, C Woodhouse, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1987

Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphomaJ A Carrasquillo, J L Mulshine, P A Bunn, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1988

Effect of antibody dose on the imaging and biodistribution of indium-111 9.2.27 anti-melanoma monoclonal antibodyJ A Carrasquillo, P G Abrams, R W Schroff, et al.

Cancer Research|May 1, 1988

Localization and imaging with radioiodine-labeled monoclonal antibodies in a xenogeneic tumor model for human B-cell lymphomaD J Buchsbaum, J A Sinkule, M S Stites, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000

Clinical and immune responses in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2K A Foon, J Lutzky, R N Baral, et al.

Pageof 19

Search research articles

Showing results (161-170 of 184) with videos related to

Sort By:

Pageof 19

Annals of Internal Medicine|October 1, 1984

Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomasP A Bunn, K A Foon, D C Ihde, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984

Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administrationR K Oldham, K A Foon, A C Morgan, et al.

Blood|November 1, 1984

Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemiaK A Foon, R W Schroff, P A Bunn, et al.

The American Journal of Medicine|March 1, 1986

Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia. Therapeutic and immunologic resultsK A Foon, A E Maluish, P G Abrams, et al.

Hybridoma|January 1, 1985

The generation of stable human T-cell hybridomas which constitutively produce interleukin-2 and chemotactic factorK A Foon, J L Rossio, R W Schroff, et al.

Cancer Research|November 15, 1987

Fate of gamma-interferon-activated killer blood monocytes adoptively transferred into the abdominal cavity of patients with peritoneal carcinomatosisH C Stevenson, A M Keenan, C Woodhouse, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1987

Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphomaJ A Carrasquillo, J L Mulshine, P A Bunn, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1988

Effect of antibody dose on the imaging and biodistribution of indium-111 9.2.27 anti-melanoma monoclonal antibodyJ A Carrasquillo, P G Abrams, R W Schroff, et al.

Cancer Research|May 1, 1988

Localization and imaging with radioiodine-labeled monoclonal antibodies in a xenogeneic tumor model for human B-cell lymphomaD J Buchsbaum, J A Sinkule, M S Stites, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000

Clinical and immune responses in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2K A Foon, J Lutzky, R N Baral, et al.

Pageof 19